BRCA1a has antitumor activity in triple-negative breast cancers

被引：0
|
作者：
C Yuli
N Shao
G Oprea-llies
J Okoli
ESP Reddy
VN Rao
机构：
[1] Cancer Biology Program,Department OB/GYN, Morehouse School of Medicine
来源：
Breast Cancer Research | / 9卷
关键词：
Breast Cancer; Estrogen Receptor; Progesterone Receptor; Antitumor Activity; Black Woman;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [21] Triple-negative breast cancers: Biomarkers and outcomes
    Malorni, L.
    Shetty, P. B.
    Hilsenbeck, S. G.
    Rimawl, M. F.
    Elledge, R. M.
    De Angelis, C.
    Osborne, C. K.
    De Placido, S.
    Arpino, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] Characterisation of distinct subgroups of BRCA1-like triple-negative breast cancers with multiomics data analysis
    Chan, T. W. S.
    Opdam, M.
    Schouten, P.
    De Boo, L.
    Hilbers, F. S.
    Linn, S. C.
    De Menezes, R. X.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S592 - S593
  • [23] 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
    Peter Bouwman
    Amal Aly
    Jose M Escandell
    Mark Pieterse
    Jirina Bartkova
    Hanneke van der Gulden
    Sanne Hiddingh
    Maria Thanasoula
    Atul Kulkarni
    Qifeng Yang
    Bruce G Haffty
    Johanna Tommiska
    Carl Blomqvist
    Ronny Drapkin
    David J Adams
    Heli Nevanlinna
    Jiri Bartek
    Madalena Tarsounas
    Shridar Ganesan
    Jos Jonkers
    Nature Structural & Molecular Biology, 2010, 17 : 688 - 695
  • [24] 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
    Bouwman, Peter
    Aly, Amal
    Escandell, Jose M.
    Pieterse, Mark
    Bartkova, Jirina
    van der Gulden, Hanneke
    Hiddingh, Sanne
    Thanasoula, Maria
    Kulkarni, Atul
    Yang, Qifeng
    Haffty, Bruce G.
    Tommiska, Johanna
    Blomqvist, Carl
    Drapkin, Ronny
    Adams, David J.
    Nevanlinna, Heli
    Bartek, Jiri
    Tarsounas, Madalena
    Ganesan, Shridar
    Jonkers, Jos
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2010, 17 (06) : 688 - U56
  • [25] Triple Negative Breast Cancer: prognosis of triple-negative breast cancers and non-triple-negative breast cancers in a large registry of certified breast units
    Kern, P.
    Rezai, M.
    CANCER RESEARCH, 2012, 72
  • [26] Discovery of metformin derivatives with potent antitumor activity in triple-negative breast cancer
    Marquez-Garban, D. C.
    Deng, G.
    Anderson, N.
    Aivazyan, L.
    Kazmi, N.
    Hamilton, N.
    Jung, M. E.
    Pietras, R. J.
    CANCER RESEARCH, 2012, 72
  • [27] Triple-negative breast cancer arising in a fibroadenoma in BRCA 1 mutated patient
    Brunetti, Nicole
    Valente, Irene
    Pitto, Francesca
    Calabrese, Massimo
    JOURNAL OF MEDICAL ULTRASOUND, 2023, 31 (01) : 63 - 65
  • [28] Evaluation of BRCA1 inactivation by promoter methylation as a markers of triple-negative and basal-like breast cancers
    Grushko, T. A.
    Nwachukwu, C.
    Charoenthammaraksa, S.
    Huo, D.
    Khramtsov, A.
    Mashek, H.
    Zhang, C.
    Xu, J.
    Perou, C. M.
    Olopade, O. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] DNA repair pathway in BRCAX and BRCA1/2-associated hereditary triple-negative breast cancers
    Domagala, P.
    Hybiak, J.
    Cybulski, C.
    VIRCHOWS ARCHIV, 2015, 467 : S64 - S64
  • [30] Triple-negative breast cancers - a panoply of cancer types
    Pareja, Fresia
    Reis-Filho, Jorge S.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (06) : 347 - 348
12345